ADVIA CENTAUR HBSAG (HBS) ASSAY

Test, Hepatitis B (b Core, Be Antigen, Be Antibody, B Core Igm)

FDA Premarket Approval P030049 S011

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Approval for the addition of two washes of the ancillary probe on the advia centaur and advia centaur xp instruments when the advia centaur hbsag assay is run immediately following the advia centaur syphilis assay.

DeviceADVIA CENTAUR HBSAG (HBS) ASSAY
Classification NameTest, Hepatitis B (b Core, Be Antigen, Be Antibody, B Core Igm)
Generic NameTest, Hepatitis B (b Core, Be Antigen, Be Antibody, B Core Igm)
ApplicantSIEMENS HEALTHCARE DIAGNOSTICS
Date Received2014-07-10
Decision Date2014-10-28
PMAP030049
SupplementS011
Product CodeLOM
Advisory CommitteeMicrobiology
Supplement TypeReal-time Process
Supplement ReasonChange Design/components/specifications/material
Expedited ReviewNo
Combination Product No
Applicant Address SIEMENS HEALTHCARE DIAGNOSTICS 333 Coney Street walpole, MA 02032-1516

Supplemental Filings

Supplement NumberDateSupplement Type
P030049Original Filing
S016 2020-12-22 Real-time Process
S015 2020-07-31 30-day Notice
S014 2020-02-21 30-day Notice
S013 2019-09-27 30-day Notice
S012 2015-06-11 30-day Notice
S011 2014-07-10 Real-time Process
S010 2012-03-26 Normal 180 Day Track No User Fee
S009
S008 2010-04-06 30-day Notice
S007 2009-05-18 Normal 180 Day Track
S006 2009-05-12 30-day Notice
S005 2009-03-31 Normal 180 Day Track
S004 2009-03-09 Normal 180 Day Track No User Fee
S003 2009-02-04 30-day Notice
S002 2008-07-30 Normal 180 Day Track
S001

NIH GUDID Devices

Device IDPMASupp
00630414472881 P030049 000
00630414472874 P030049 002
00630414472867 P030049 002

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.